SCHEMBL4666864

SCHEMBL4666864

CCc1cccc(-c2cc(N)n(-c3nc(C)cnc3C)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.45
NPC1 O15118 7/20 0.45
RAB9A P51151 7/20 0.45
NFKB1 P19838 3/20 0.45
NFKB2 Q00653 3/20 0.45
RELA Q04206 3/20 0.45
ALDH1A1 P00352 5/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
IDO1 P14902 1/20 0.40
PIK3CA P42336 1/20 0.38
BACE1 P56817 1/20 0.38
MAPT P10636 6/20 0.37
STAT1 P42224 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668551 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL14600480 0.77 IDO1 (0.32) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL4666570 0.77 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL14600209 0.76 GFER (0.42) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL14600670 0.75 DHODH (0.45) TP53
SCHEMBL4665083 0.74 MAPT (0.46) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL4665764 0.74 NOS3 (0.34) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL4669491 0.74 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL14600483 0.74 CTSV (0.37) MAPTTP53LMNA
SCHEMBL14600485 0.74 KMT2A (0.37) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed